Company intelligence

ENSC

Ensysce Biosciences, Inc. · NASDAQ · Healthcare

Price$0.40+11.63% · +$0.04

Market cap6.19MEquity value

P / E-0.1Trailing ratio

Volume1.63MLatest session

Market data

ENSC price chart

TradingView

Related signals

1 min delayed

Browse public ENSC signals with their source context and measured market impact. Open any signal for its permanent analysis page.

ENSCFeb 27, 2026-8.11% since signal

Ensysce Biosciences Initiates Strategic Review to Boost Shareholder Value

Ensysce Biosciences has launched a strategic review aimed at enhancing shareholder value through various potential avenues, including partnerships and licensing. This move could catalyze investment interest and boost stock performance, particularly for its innovative platforms.

View signal analysis

ENSCApr 23, 2025-9.81% since signal

Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why

ENSC's stock surged nearly 100% with increased trading volume. Received patent approval for PF9001 aimed at opioid use disorder treatment. PF9001 reduces cardiotoxicity and overdose risks, significant advancements for OUD. Successful trial data supports PF614-MPAR's safety for severe pain management. Upcoming trials will refine drug product for commercialization.

View signal analysis

Research